PIB Headquarters
PIB’S BULLETIN ON COVID-19
|
|
- India’s cumulative vaccination coverage crosses 97 crore landmark milestone
- More than 27 lakh Vaccine doses administered today till 7 pm
- 18,987 new cases in the last 24 hours
- Recovery Rate currently at 98.07%; Highest since March 2020
- 19,808recoveries in the last 24 hours increases Total Recoveries to 3,33,62,709
- Active cases account for less than 1% of total cases, currently at 0.61%; Lowest since March 2020
- India's Active caseload stands at 2,06,586; lowest in 215 days
- Weekly Positivity Rate  less than 3% for last 111 days
- Daily positivity rate less than 3% for last 45 days
- 58.76 crore Total Tests conducted so far
#Unite2FightCorona#IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
COVID-19 Update
India’s cumulative vaccination coverage crosses 97 crore landmark milestone
More than 27 lakh Vaccine doses administered today till 7 pm
Recovery Rate currently at 98.07%; Highest since March 2020
18,987 New Cases reported in the last 24 hours
India's Active Caseload  is 0.61% of Total Cases
Weekly Positivity Rate  less than 3% for last 111 days
India’s COVID-19 vaccination coverage has achieved 97 Crore landmark milestone  today. More than 27 lakh  Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.
The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:
|
|
Cumulative Vaccine Dose Coverage
|
|
HCWs
|
|
1st Dose
|
|
10375693
|
|
2nd Dose
|
|
9065616
|
|
FLWs
|
|
1st Dose
|
|
18361083
|
|
2nd Dose
|
|
15482139
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
391045406
|
|
2nd Dose
|
|
108093471
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
167206130
|
|
2nd Dose
|
|
85245072
|
|
Over 60 years
|
|
1st Dose
|
|
105467791
|
|
2nd Dose
|
|
60778004
|
|
Cumulative 1st dose administered
|
|
692456103
|
|
Cumulative 2nd dose administered
|
|
278664302
|
|
Total
|
|
971120405
Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:
|
|
Date: 14thOctober, 2021 
|
|
HCWs
|
|
1st Dose
|
|
51
|
|
2nd Dose
|
|
6816
|
|
FLWs
|
|
1st Dose
|
|
646
|
|
2nd Dose
|
|
25060
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
892766
|
|
2nd Dose
|
|
1009715
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
209825
|
|
2nd Dose
|
|
321540
|
|
Over 60 years
|
|
1st Dose
|
|
124329
|
|
2nd Dose
|
|
171775
|
|
1st Dose Administered in Total
|
|
1227617
|
|
2nd Dose Administered in Total
|
|
1534906
|
|
Total
|
|
2762523
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.
The recovery of 19,808 patients in the last 24 hours has increased the cumulative tally of recovered patients  to 3,33,62,709.
Consequently, India’s recovery rate stands at 98.07%. Recovery Rate is currently at its highest peak since March 2020.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 109 consecutive days now.
18,987 new cases were reported in the last 24 hours.
The Active Caseload is presently 2,06,586, which is the lowest in 215 days.Active cases presently constitute 0.61% of the country's total Positive Cases.
The testing capacity across the country continues to be expanded. The last 24 hours saw a total of
13,01,083tests being conducted. India has so far conducted over 58.76 Cr  cumulative tests.
While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.44% remains less than 3% for the last 111 days now. The Daily Positivity rate reported to be1.46%. The daily Positivity rate has remained below 3% for last 45 days and below 5% for 128 consecutive days now.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1763784
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1764021
Update on COVID-19 Vaccine Availability in States/UTs
More than 98.88 Crore vaccine doses provided to States/UTs
More than 8.89 Crore balance and unutilized vaccine doses still available with States/UTs
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply  75% of the vaccines being produced by the vaccinemanufacturers in the country to States and UTs.
|
|
VACCINE DOSES
|
|

|
|
SUPPLIED
|
|
98,88,80,235
|
|
BALANCE AVAILABLE
|
|
8,89,08,435
More than 98.88 crore  vaccine doses have been provided to States/UTs so far through Govt of India  and through direct state procurement category.
More than 8.89 Cr  balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1763781
Country’s first ‘One Health’ consortium launched by D/o Biotechnology, Post COVID 19
COVID-19 pandemic showed the relevance of ‘One Health’ principles in the governance of infectious diseases, specially efforts to prevent and contain zoonotic diseases throughout the world. The risk of infectious agents capable of jumping the barriers of species is increasing, mainly because of the potential of novel infectious agents to spread rapidly around the globe due to increased travel, food habits and trade across borders . Such diseases have devastating impacts on animals, human, health systems, and economies, requiring years of social and economic recovery. Sensing this urgent need, the Department of Biotechnology , Ministry of Science and Technology, GoI supported a mega consortium on ‘One Health’. Dr. Renu Swarup, Secretary, Department of Biotechnology, Govt. of launched the First ‘One Health’ project of DBT through video conferencing. This programme envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens in India, including the North-eastern part of the country. Use of existing diagnostic tests and the development of additional methodologies when required are mandated for the surveillance and for understanding the spread of emerging diseases.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1763772
Important Tweets